New Diabetes With CKD in an Uninsured Patient: Sequencing Care
58-year-old man with newly diagnosed type 2 diabetes, BMI 32, A1c 10.1%, BP 152/90, eGFR 36, UACR 420 mg/g, LDL 140. He is uninsured, works as a day laborer, and cannot afford brand-name medications. He has no symptoms of hyperglycemia except fatigue and nocturia. He has no regular primary care. He occasionally checks his blood glucose with a borrowed meter and reports values of 180–300 mg/dL. He speaks Spanish and prefers a Spanish-speaking clinician. He is motivated to avoid dialysis because his brother recently started it.
1. Which medication and monitoring plan would you prioritize at this visit, given his eGFR, albuminuria, cost constraints, and A1c? Explain your reasoning.
Read the worked answer
I would start an ACE inhibitor or ARB, such as lisinopril, for albuminuria and blood pressure, plus a statin, both available as low-cost generics. I would not initiate metformin because his eGFR is 36 mL/min/1.73 m2; if he were already taking it, I would limit the dose and monitor. An SGLT2 inhibitor is preferred for kidney and cardiovascular protection in diabetic CKD, but cost is a major barrier. I would first check patient-assistance programs and 340B pricing; if truly unaffordable, I would use basal insulin, such as NPH, or low-dose glipizide to address the A1c of 10.1%, while avoiding glyburide. I would recheck potassium and creatinine in 1 to 2 weeks after starting the ACE inhibitor or ARB, provide diabetes education, and arrange a Spanish interpreter and close follow-up. The plan must balance guideline-directed therapy with actual access.
2. What barriers to care are present, and how would you address them to improve adherence and outcomes?
Read the worked answer
He is uninsured, works as a day laborer, speaks Spanish, lacks a regular clinician, and cannot afford brand-name drugs. These barriers increase the risk of untreated hypertension, progressive CKD, and hyperglycemia. I would involve social work and a community health worker, use generic medications and pharmacy assistance, provide Spanish-language teaching and interpreter services, and offer evening or telehealth visits that fit his work schedule. I would simplify the regimen, write prescriptions for low-cost pharmacies, and connect him with a federally qualified health center. Checking his glucose with a borrowed meter is unreliable; I would provide a low-cost meter and strips if possible and teach sick-day rules. Follow-up should include A1c, blood pressure, urine albumin, and renal function.
3. When would you refer to nephrology, and what would you communicate?
Read the worked answer
I would refer now or soon rather than waiting, because he has an albumin-to-creatinine ratio above 300 mg/g and an eGFR of 36 mL/min/1.73 m2, both of which meet criteria for nephrology involvement in diabetic kidney disease. I would communicate the new diabetes diagnosis, blood pressure, eGFR trend, albuminuria, current medications, cost barriers, and social situation. I would ask for co-management of CKD progression, blood pressure targets, and medication access. I would also clarify whether the kidney disease is likely diabetic or has another cause, and whether additional testing is needed. Early referral can help prevent progression to dialysis, which is his stated goal.